IPO Trending
SENORESEQ / NSE, BSEListed

Senores Pharmaceuticals Limited

Senores Pharmaceuticals Limited, incorporated on December 26, 2017, is an Ahmedabad-based pharmaceutical company focused on developing, manufacturing, and marketing high-quality branded generic medicines for both domestic and global markets. Its diversified product portfolio spans key therapeutic areas, including gastrointestinal, cardiovascular, respiratory, pain management, and anti-infective segments. Driven by strong R&D capabilities, the company emphasizes innovation, cost-effective product development, and strict regulatory compliance. Senores operates through a robust distribution network supported by subsidiaries such as Ratnatris Pharmaceuticals Private Limited and Havix Group, Inc. (Aavis Pharmaceuticals). It serves customers across major international markets, including the US, Europe, and other emerging regions.

₹372 - ₹39197.25x sub
Listed Price600.00
Listing Gain+53.45%
TimelineBookbuilding IPO
Open20 Dec 2024
Close24 Dec 2024
Allotment26 Dec 2024
Listing30 Dec 2024

Quota Reservation Portions

QIBPortion: 44,43,818 shares
54.05%
HNIPortion: 22,21,909 shares
27.02%
RetailPortion: 14,81,272 shares
18.02%
EmployeePortion: 75,000 shares
0.91%

Minimum Application Bracket Matrix

Retail1 lots / 38 shares
₹14,858
sHNI14 lots / 532 shares
₹2,08,012
bHNI68 lots / 2,584 shares
₹10,10,344

About the Company

Senores Pharmaceuticals Limited, incorporated on December 26, 2017, is an Ahmedabad-based pharmaceutical company focused on developing, manufacturing, and marketing high-quality branded generic medicines for both domestic and global markets. Its diversified product portfolio spans key therapeutic areas, including gastrointestinal, cardiovascular, respiratory, pain management, and anti-infective segments. Driven by strong R&D capabilities, the company emphasizes innovation, cost-effective product development, and strict regulatory compliance. Senores operates through a robust distribution network supported by subsidiaries such as Ratnatris Pharmaceuticals Private Limited and Havix Group, Inc. (Aavis Pharmaceuticals). It serves customers across major international markets, including the US, Europe, and other emerging regions.

Company Promoters

Swapnil Jatinbhai ShahAshokkumar Vijaysinh Barot